Hailey Biotech (603718.SH): Net loss of 3.719 million yuan in the first quarter

Gelonghui, April 29丨Hailey Biotech (603718.SH) released its first quarter report. Operating revenue was 70.3 million yuan, down 1.31% year on year, net loss of 3.79 million yuan, net loss of 5.29 million yuan after non-net loss, and basic earnings per share -0.01 yuan.

Gelonghui Finance45minutes ago

China Animal Husbandry Co., Ltd. (600195.SH)'s net profit for the first quarter of 76.53 million yuan decreased by 45.53% year-on-year

On April 29, Ge Longhui Co., Ltd. (600195.SH) announced that in the first quarter of 2024, the company's operating income was 1,125 billion yuan, up 5.97% year on year; net profit attributable to shareholders of listed companies was 76.53 million yuan, a year-on-year decrease of 45.53%; and basic earnings per share were 0.0749 yuan/share.

Gelonghui Finance04:03 ET

Keqian Biotech (688526.SH): Net profit of 87.228 million yuan in the first quarter decreased 35.64% year-on-year

On April 29, Ge Longhui Biotech (688526.SH) released its first quarter report. Operating revenue was 200 million yuan, down 26.68% year on year, net profit was 87.228 million yuan, down 35.64% year on year, after deducting non-net profit of 76.1578 million yuan, down 40.56% year on year, with basic earnings of 0.18 yuan per share.

Gelonghui Finance03:41 ET

Jinhe Biotech (002688.SZ): 2023 net profit of 86.457 million yuan increased 14.34% year-on-year

On April 28, Gelonghui Biotech (002688.SZ) released its 2023 annual report. The revenue for the reporting period was 2.174 billion yuan, an increase of 2.42% over the previous year. Net profit attributable to shareholders of listed companies was 86.457 million yuan, an increase of 14.34% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 779.329 million yuan, an increase of 12.76% over the previous year. Basic earnings per share were $0.1108. It is proposed to distribute a cash dividend of 1.00 yuan (tax included) for every 10 shares to all shareholders.

Gelonghui FinanceApr 28 09:03 ET

What You Need To Know About The Pulike Biological Engineering, Inc. (SHSE:603566) Analyst Downgrade Today

One thing we could say about the analysts on Pulike Biological Engineering, Inc. (SHSE:603566) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forec

Simply Wall StApr 27 20:59 ET

Shenlian Biotech (688098.SH): Net loss of 2.09 million yuan in the first quarter

Gelonghui, April 26 | Shenlian Biotech (688098.SH) released its first quarter report. Operating revenue was 880.58 million yuan, up 7.58% year on year, with a net loss of 2.209 million yuan, after deducting non-net loss of 2.889 million yuan, and basic earnings per share of -0.01 yuan.

Gelonghui FinanceApr 26 06:15 ET